KORU Medical Systems Stock

KORU Medical Systems Equity

The The Equity of KORU Medical Systems (KRMD) as of Aug 18, 2026 is 17.05 M USD. In the previous year, The Equity was 16.81 M USD — a change of 1.39% (higher).

Equity

17.05 MUSD

YoY

1.39%

Last updated:

In 2026, KORU Medical Systems's equity was 17.05 M USD, a 1.39% increase from the 16.81 M USD equity in the previous year.

Access this data via the Eulerpool API

KORU Medical Systems Stock analysis

What does KORU Medical Systems do? Repro Med Systems Inc is a US-based company specializing in the development and manufacturing of medical devices for infusion therapy. The company was founded in 1980 by Edward L. Swanson and is headquartered in Chester, New York. Repro Med Systems Inc started as a small family business developing medical devices for reproductive medicine. Over the years, the company expanded and began focusing on other medical applications. In the 1990s, the company developed an innovative infusion pump system, later known as the "Freedom Syringe Infusion System." This system received numerous patents and proved to be a groundbreaking innovation in infusion therapy. Repro Med Systems Inc specializes in selling medical devices for infusion therapy. The company uses a direct sales model, allowing them to sell products directly to end customers. This enables the company to better understand customer needs and quickly respond to industry changes. Repro Med Systems Inc offers a variety of products for infusion therapy, including the "Freedom Syringe Infusion System," the "MRidium" infusion pump system, and the "Freo" intermittent dosing infusion pump system. The "Freedom Syringe Infusion System" is a portable infusion pump system that allows the administration of medications and fluids through a needleless disposable syringe. The system is easier to use than conventional infusion pumps and provides patients with more freedom and mobility during treatment. The "MRidium" infusion pump system has been specifically designed for use in magnetic resonance imaging (MRI). The system is immune to magnetic interference and can be used during an MRI examination to provide patients with infusions. The "Freo" intermittent dosing infusion pump system is a simple and reliable system that allows the administration of medications in variable doses. The system is ideal for pain management and enables patients to administer their medications quickly and easily. In conclusion, Repro Med Systems Inc is an innovative company specializing in the development and manufacturing of medical devices for infusion therapy. The company has experienced remarkable growth in recent years and is now a key player in the industry. With its focus on innovation and customer satisfaction, the company is expected to continue to be successful in the future. KORU Medical Systems is one of the most popular companies on Eulerpool.

Equity Details

Analyzing KORU Medical Systems's Equity

KORU Medical Systems's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding KORU Medical Systems's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating KORU Medical Systems's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

KORU Medical Systems's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in KORU Medical Systems’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about KORU Medical Systems stock

The Equity of KORU Medical Systems is 17.05 M USD in 2026.

The Equity of KORU Medical Systems changed from 16.81 M USD to 17.05 M USD, representing a 1.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity KORU Medical Systems since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's KORU Medical Systems historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — KORU Medical Systems

All Key Metrics — KORU Medical Systems